These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Sublingual and oral immunotherapy.
    Author: Canonica GW, Compalati E, Fumagalli F, Passalacqua G.
    Journal: Immunol Allergy Clin North Am; 2004 Nov; 24(4):685-704, vii. PubMed ID: 15474866.
    Abstract:
    Sublingual immunotherapy (SLIT) is a viable alternative to the subcutaneous route for the treatment of respiratory allergy, whereas the pure oral route has been abandoned because of its lack of efficacy. The main distinctive feature of SLIT is its optimal safety profile, which has been demonstrated in adults and children. The indications for SLIT are similar to those for the subcutaneous route. A long-lasting effect has been demonstrated for the sublingual route, but data are needed to determine the optimal dose and the preventive effect in asthma.
    [Abstract] [Full Text] [Related] [New Search]